Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 
OFFON

4-Traders Homepage  >  Equities  >  Nyse  >  Allergan, Inc.    AGN

SummaryQuotesNewsCalendarCompanyFinancials 
News SummaryMost relevantAll newsSector news 
Latest news on ALLERGAN, INC.
12/03 CADILA HEALTHCARE : Zydus announces settlement of patent litigation
12/03 ALLERGAN, INC. : Pomerantz Law Firm Reminds Shareholders with Losses on their In..
12/02 ALLERGAN PLC (NYSE : AGN) Files An 8-K Regulation FD Disclosure
12/02 ALLERGAN PLC : Regulation FD Disclosure, Financial Statements and Exhibits (form..
12/02 Pharma execs weigh in on possible changes under Trump
12/01 ALLERGAN, INC. : SHAREHOLDER ALERT - Bronstein, Gewirtz & Grossman, LLC Reminds ..
11/30 ALLERGAN : More than 200 women now claim breast-implant surgeries were botched
11/29 BIG PHARMA’S TAX-DODGING HISTO : Actavis ‘inversions’ won it b..
11/24 CIPLA : EU divests stake in Chase Pharmaceuticals to Allergan
11/24 ALLERGAN : Assigned Patent
11/24 CIPLA : Divests stake in us firm chase pharma to allergan
11/23 Lilly's drug for Alzheimer's fails big trial; shares drop
11/23 ALLERGAN, INC. : Bronstein, Gewirtz & Grossman, LLC Reminds Investors of Class A..
11/23 CIPLA : EU divests stake in Chase Pharmaceuticals to Allergan
11/22 ALLERGAN : Receives FDA Clearance for the XEN Gel Stent
11/21 ALLERGAN : Receives Canadian Approval for Long Term Treatment with Fibristal
11/17 ASTRAZENECA : AZ out-licensing deal with Allergan completed
11/16 Global Botulinum Market 2016- Allergan, Ipsen, Merz, US WorldMeds, Medytox, L..
11/16 ALLERGAN : AGN) Files An 8-K Departure of Directors or Certain Officers; Electio..
11/16 ALLERGAN, INC. : Bronstein, Gewirtz & Grossman, LLC Notifies Investors of Class ..
11/16 ALLERGAN : Announces Partnership with Amy Dixon, Elite Paratriathlete
11/16 ALLERGAN : Announces Partnership with Amy Dixon, Elite Paratriathlete, to Improv..
11/16 ALLERGAN : Assigned Patent
11/16 ALLERGAN : Pharma Shares Flying Out Of Windows Of First-Class Car On The Trump T..
11/15 ALLERGAN PLC : Change in Directors or Principal Officers (form 8-K)
11/15 Teva trims 2016 outlook on drug launch delays
11/15 S&P 500 MOVERS : Endp, aap
11/12 ALLERGAN : Sofregen Medical Acquires SERI Surgical Scaffold Product Line from Al..
11/12 ALLERGAN, INC. : Lundin Law PC Announces Securities Class Action Lawsuit against..
11/11 ALLERGAN, INC. : Khang & Khang LLP Announces Securities Class Action Lawsuit aga..
11/10 ALLERGAN, INC. : Lundin Law PC Announces Securities Class Action Lawsuit against..
11/10 ALLERGAN PLC (AGN) INVESTOR ALERT : Lawsuit Alleges False and Misleading Stateme..
11/10 Amri announces third quarter 2016 results
11/10 ALLERGAN : Announces Launch of TAYTULLA™ (Norethindrone Acetate and Ethiny..
11/10 ALLERGAN : Top Plastic Surgeon, Dr. Paul Vitenas, Now Offers Patients New Dermal..
11/09 ALLERGAN : Top Plastic Surgeon, Dr. Paul Vitenas, Now Offers Patients New Dermal..
11/09 ALLERGAN : AGN) Pops 8.73% for November 09
11/07 ALLERGAN : Analysts put Teva's exposure at $700m
11/06 ALLERGAN : Teva slide gains momentum amid price-fixing reports
11/04 ALLERGAN : MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESUL..
11/04 ALLERGAN, INC. : Bronstein, Gewirtz & Grossman, LLC Announces Investigation of A..
11/04 Drugmakers under fire for possible U.S. price fixing
11/04 ALLERGAN : Revenues Increase, Per Third Quarter Report
11/03 ALLERGAN : AGN) Falls 4.58% for November 03
11/02 ALLERGAN PLC (NYSE : AGN) Files An 8-K Announces $10 Billion Accelerated Share R..
11/02 Allergan CEO takes blame for big miss on quarterly earnings
11/02DJU.S. HOT STOCKS : Hot Stocks to Watch
11/02 ALLERGAN : Assigned Patent
11/02 ALLERGAN : misses Street 3Q forecasts
11/02 ALLERGAN PLC : Results of Operations and Financial Condition, Financial Statemen..
11/02 ALLERGAN PLC : Regulation FD Disclosure, Financial Statements and Exhibits (form..
11/02 T2 BIOSYSTEMS : Announces Collaboration with Allergan to Develop the First Blood..
10/31 ALLERGAN PLC : Change in Directors or Principal Officers (form 8-K)
10/28 ALLERGAN : Introduces RESTASIS MULTIDOSE™ (Cyclosporine Ophthalmic Emulsio..
10/26 ALLERGAN : Announces Changes to Board Leadership
10/26 ALLERGAN : Assigned Patent
10/20 ALLERGAN : First and Only FDA-Approved Lip Filler Available This Fall In Newburg..
10/19 ALLERGAN : First and Only FDA-Approved Lip Filler Available This Fall In Newburg..
10/19 ALLERGAN : Assigned Patent
10/18 ALLERGAN : Carmel doctor among first to offer treatment for lip lines
10/18 ALLERGAN : to use UroGen system for Botox delivery
10/18 ALLERGAN : JUVÉDERM VOLBELLA® XC Now Available To Doctors And Patients In The U...
10/17 ALLERGAN : Global Virus Network Announces $100,000 Donation from The Allergan Fo..
10/16 ALLERGAN : Demonstrates Ongoing Commitment to Irritable Bowel Syndrome (IBS) wit..
10/14 ALLERGAN : Demonstrates Continued Commitment to Irritable Bowel Syndrome with Di..
10/14 U.S. targets corporate tax-reduction strategy with new regulation
10/13 ALLERGAN : BELKYRA® (Deoxycholic Acid) Receives Marketing Authorisation In Swede..
10/12 PROCTER & GAMBLE : Nestl Skin Health names Allergan veteran Navarre as new CEO
10/06 ALLERGAN PLC : Results of Operations and Financial Condition, Regulation FD Disc..
10/06 ALLERGAN : Teva, Mylan shares at 2-year lows
10/06 ALLERGAN : Indian giant snaps up UK pharma business
10/05 Teva to sell Allergan's generics business in UK, Ireland for $769 million
10/05 AstraZeneca licenses respiratory drug to Insmed
10/05 ALLERGAN : Cacti Asset Management LLC Purchases 3,025 Shares of Allergan PLC (AG..
10/04 ALLERGAN : Another Acquisition for Allergan Makes Six Since August
1  2  3  4  5  6  7  8  9  10Next
Advertisement
Income Statement Evolution
More Financials
Managers
NameTitle
Ambrose Robert Douglas Bailey Chairman & President
Scott M. Whitcup Chief Scientific Officer & Executive VP-Research
Raymond H. Diradoorian Executive VP-Global Technical Operations
Maria Teresa Hilado Director
Joann Bradley Investor Relations Contact
More about the company
Sector and Competitors
1st jan.Capitalization (M$)
ALLERGAN, INC.13.00%0
JOHNSON & JOHNSON9.00%304 591
PFIZER INC.-2.01%191 942
ROCHE HOLDING LTD.-19.61%188 878
NOVARTIS AG-19.07%178 737
MERCK & CO., INC.15.85%168 544
More Results